Dacarbazine Injection 100 (ダカルバジン注用100)

Land: Japan

Sprache: Englisch

Quelle: すりの適正使用協議会 RAD-AR Council, Japan

Kaufe es jetzt

Herunterladen Gebrauchsinformation (PIL)
01-09-2021

Wirkstoff:

Dacarbazine

Verfügbar ab:

SANDOZ K.K.

INN (Internationale Bezeichnung):

Dacarbazine

Darreichungsform:

injection

Gebrauchsinformation

                                Drug Information Sheet("Kusuri-no-Shiori")
Injection
Published: 09/2021
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
DACARBAZINE INJECTION 100
ACTIVE INGREDIENT:
Dacarbazine
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine shows antineoplastic activity by combining with DNA of
cancer cells and
inhibiting DNA replication.
It is usually used to treat malignant melanoma, Hodgkin's disease
(Hodgkin's lymphoma), and
pheochromocytoma.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you have hepatic or renal disorder, infection, varicella.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         
           
to be written by a healthcare
professional
))
・For malignant melanoma: In general, for adults, this medicine is
injected intravenously and
then discontinue temporarily. This dosing schedule is repeated.
・For Hodgkin's disease (Hodgkin's lymphoma): In general, for both of
adults and children, this
medicine is injected intravenously once a day and then discontinue
temporarily. This dosing
schedule is repeated.
・For pheochromocytoma: In general, for adults, this medicine is
injected intravenously once a
da
                                
                                Lesen Sie das vollständige Dokument
                                
                            

Suchen Sie nach Benachrichtigungen zu diesem Produkt